keyword
MENU ▼
Read by QxMD icon Read
search

Fecal immunochemical testing

keyword
https://www.readbyqxmd.com/read/28938500/acceptability-of-two-colorectal-cancer-screening-tests-pain-as-a-key-determinant-in-sigmoidoscopy
#1
Benedicte Kirkøen, Paula Berstad, Edoardo Botteri, Eirin Dalén, Jens Aksel Nilsen, Geir Hoff, Thomas de Lange, Tomm Bernklev
Background Participants' experience with a screening test can influence adherence, and therefore the efficacy of screening programs. We compared screening with unsedated flexible sigmoidoscopy and fecal immunochemical testing (FIT) for participants' satisfaction with the decision and for willingness to repeat colorectal cancer screening. Methods In a prospective, randomized trial 3257 individuals (50 - 74 years) were invited to either flexible sigmoidoscopy or FIT (1:1), of whom 1650 took up the offer (52...
September 22, 2017: Endoscopy
https://www.readbyqxmd.com/read/28923816/-finding-the-right-fit-rural-patient-preferences-for-fecal-immunochemical-test-fit-characteristics
#2
Robyn Pham, Suzanne Cross, Bianca Fernandez, Kathryn Corson, Kristen Dillon, Coco Yackley, Melinda M Davis
PURPOSE: Colorectal cancer (CRC) is the third leading cause of cancer death in the United States, yet 1 in 3 Americans have never been screened for CRC. Annual screening using fecal immunochemical tests (FITs) is often a preferred modality in populations experiencing CRC screening disparities. Although multiple studies evaluate the clinical effectiveness of FITs, few studies assess patient preferences toward kit characteristics. We conducted this community-led study to assess patient preferences for FIT characteristics and to use study findings in concert with clinical effectiveness data to inform regional FIT selection...
September 2017: Journal of the American Board of Family Medicine: JABFM
https://www.readbyqxmd.com/read/28923806/improving-the-health-of-patients-and-communities-evolving-practice-based-research-pbr-and-collaborations
#3
Kevin Fiscella
This issue illustrates how research from practice-based research networks has evolved to span a spectrum from improving patient-level care and practice quality to improving health within local and global communities. Articles address patient-level improvements (a biomarker for cardiovascular disease progression, late-onset anorexia nervosa, complementary health approaches used by patients, and patient preferences related to antibiotics for acute respiratory infections); practice-level improvements (selection of types of fecal immunochemical tests, practice facilitation, practice registry implementation, community-based outreach, and bidirectional texting); and community-level improvements (primary care-public health partnership, influenza surveillance, and establishing family medicine training abroad)...
September 2017: Journal of the American Board of Family Medicine: JABFM
https://www.readbyqxmd.com/read/28873508/fecal-immunochemical-test-and-fecal-calprotectin-results-show-different-profiles-in-disease-monitoring-for-ulcerative-colitis
#4
Sakiko Hiraoka, Toshihiro Inokuchi, Asuka Nakarai, Shiho Takashima, Daisuke Takei, Yuusaku Sugihara, Masahiro Takahara, Keita Harada, Hiroyuki Okada, Jun Kato
Background/Aims: Both fecal immunochemical test (FIT) and fecal calprotectin (Fcal) results are useful biomarkers for ulcerative colitis (UC). However, the situations in which each marker should be used are largely unknown. Methods: A total of 110 colonoscopy intervals of UC patients were assessed, and correlations between changes in colonoscopic findings and changes in the two aforementioned fecal markers were examined. Results: Among patients with mucosal healing (MH) and negative FIT or Fcal results at the initial colonoscopy, FIT and Fcal findings exhibited accuracies of 93% (38/41) and 79% (26/33), respectively, for predicting the results of the subsequent examination...
September 7, 2017: Gut and Liver
https://www.readbyqxmd.com/read/28873161/effect-of-colonoscopy-outreach-vs-fecal-immunochemical-test-outreach-on-colorectal-cancer-screening-completion-a-randomized-clinical-trial
#5
RANDOMIZED CONTROLLED TRIAL
Amit G Singal, Samir Gupta, Celette Sugg Skinner, Chul Ahn, Noel O Santini, Deepak Agrawal, Christian A Mayorga, Caitlin Murphy, Jasmin A Tiro, Katharine McCallister, Joanne M Sanders, Wendy Pechero Bishop, Adam C Loewen, Ethan A Halm
Importance: Mailed fecal immunochemical test (FIT) outreach is more effective than colonoscopy outreach for increasing 1-time colorectal cancer (CRC) screening, but long-term effectiveness may need repeat testing and timely follow-up for abnormal results. Objective: Compare the effectiveness of FIT outreach and colonoscopy outreach to increase completion of the CRC screening process (screening initiation and follow-up) within 3 years. Design, Setting, and Participants: Pragmatic randomized clinical trial from March 2013 to July 2016 among 5999 participants aged 50 to 64 years who were receiving primary care in Parkland Health and Hospital System and were not up to date with CRC screenings...
September 5, 2017: JAMA: the Journal of the American Medical Association
https://www.readbyqxmd.com/read/28873160/effect-of-physician-notification-regarding-nonadherence-to-colorectal-cancer-screening-on-patient-participation-in-fecal-immunochemical-test-cancer-screening-a-randomized-clinical-trial
#6
RANDOMIZED CONTROLLED TRIAL
Cédric Rat, Corinne Pogu, Delphine Le Donné, Chloé Latour, Gaelle Bianco, France Nanin, Anne Cowppli-Bony, Aurélie Gaultier, Jean-Michel Nguyen
Importance: Increasing participation in fecal screening tests is a major challenge in countries that have implemented colorectal cancer (CRC) screening programs. Objective: To determine whether providing general practitioners (GPs) a list of patients who are nonadherent to CRC screening enhances patient participation in fecal immunochemical testing (FIT). Design, Setting, and Participants: A 3-group, cluster-randomized study was conducted from July 14, 2015, to July 14, 2016, on the west coast of France, with GPs in 801 practices participating and involving adult patients (50-74 years) who were at average risk of CRC and not up-to-date with CRC screening...
September 5, 2017: JAMA: the Journal of the American Medical Association
https://www.readbyqxmd.com/read/28843582/diagnosis-of-sessile-serrated-adenoma-after-educational-training-in-a-large-community-based-integrated-healthcare-setting
#7
Dan Li, John Woolfrey, Sheng-Fang Jiang, Christopher D Jensen, Wei K Zhao, Sanjay Kakar, Monica Santamaria, Greg Rumore, Mary Anne Armstrong, Debbie Postlethwaite, Douglas A Corley, Theodore R Levin
BACKGROUND AND AIMS: Sessile serrated adenomas (SSAs) are precursors of 15% to 30% of colorectal cancers but are frequently underdiagnosed. We sought to measure the SSA detection rate (SDR) and predictors of SSA detection after educational training for community gastroenterologists and pathologists. METHODS: Colonoscopy and pathology data (2010-2014) from 3 medical centers at Kaiser Permanente Northern California were accessed electronically. Gastroenterologists and pathologists attended a training session on SSA diagnosis in 2012...
August 23, 2017: Gastrointestinal Endoscopy
https://www.readbyqxmd.com/read/28812930/increasing-colorectal-cancer-screening-at-an-urban-fqhc-using-ifobt-and-patient-navigation
#8
Richard L Martin, Madelaine Tully, Allison Kos, David Frazer, Amy Williamson, Amy Conlon, James J Enser, Noelle K LoConte
INTRODUCTION: Colorectal cancer is the second leading cause of cancer death in the United States. Black Americans suffer even higher incidence and death rates than the general population. Genetics and patient perceptions explain some of this difference, however, modifiable health care system factors such as lack of access to colon cancer screening also contribute. Partnering an academic health center with local community groups, we piloted a colorectal cancer screening program at a Federally Qualified Health Center (FQHC) serving predominately low socioeconomic status Black Americans...
September 2017: Health Promotion Practice
https://www.readbyqxmd.com/read/28804030/development-and-validation-of-trigger-algorithms-to-identify-delays-in-diagnostic-evaluation-of-gastroenterological-cancer
#9
Daniel R Murphy, Ashley N D Meyer, Viralkumar Vaghani, Elise Russo, Dean F Sittig, Li Wei, Louis Wu, Hardeep Singh
BACKGROUND & AIMS: Colorectal cancer (CRC) and hepatocellular cancer (HCC) are common causes of death and morbidity, and patients benefit from early detection. However, delays in follow-up of suspicious findings are common, and methods to efficiently detect such delays are needed. We developed, refined, and tested trigger algorithms that identify patients with delayed follow-up evaluation of findings suspicious of CRC or HCC. METHODS: We developed and validated two trigger algorithms that detect delays in diagnostic evaluation of CRC and HCC using laboratory, diagnosis, procedure, and referral codes from the Department of Veteran Affairs National Corporate Data Warehouse...
August 10, 2017: Clinical Gastroenterology and Hepatology
https://www.readbyqxmd.com/read/28796231/impact-of-fecal-hb-levels-on-advanced-neoplasia-detection-and-the-diagnostic-miss-rate-for-colorectal-cancer-screening-in-high-risk-vs-average-risk-subjects-a-multi-center-study
#10
Satimai Aniwan, Thawee Ratanachu-Ek, Supot Pongprasobchai, Julajak Limsrivilai, Ong-Ard Praisontarangkul, Pises Pisespongsa, Pisaln Mairiang, Apichat Sangchan, Jaksin Sottisuporn, Naruemon Wisedopas, Pinit Kullavanijaya, Rungsun Rerknimitr
OBJECTIVES: The Asia-Pacific Colorectal Screening (APCS) scoring system was developed to identify high-risk subjects for advanced neoplasia. However, the appropriate fecal immunochemical test (FIT) cutoff for high-risk population may be different from that of average-risk population. We aimed to evaluate the FIT performance at different cutoffs in high-risk subjects undergoing colorectal cancer (CRC) screening. METHODS: We prospectively enrolled asymptomatic subjects aged 50-75 years...
August 10, 2017: Clinical and Translational Gastroenterology
https://www.readbyqxmd.com/read/28792133/a-combination-of-fecal-immunochemical-test-results-and-iron-deficiency-anemia-for-detection-of-advanced-colorectal-neoplasia-in-asymptomatic-men
#11
Nam Hee Kim, Mi Yeon Lee, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
PURPOSE: A substantial proportion of patients with colorectal cancer (CRC) present with iron deficiency anemia (IDA), and fecal immunochemical test (FIT) has proven to be an effective method for detecting the majority of CRC cases. A combination strategy of FIT results and IDA may be useful for risk stratification for detecting advanced colorectal neoplasia (ACRN). We compared the prevalence of ACRN among four groups stratified by FIT results and the presence of IDA. MATERIALS AND METHODS: A cross-sectional study was performed on asymptomatic male participants who underwent both FIT and colonoscopy between 2010 and 2014 as part of a comprehensive health screening program in Korea...
September 2017: Yonsei Medical Journal
https://www.readbyqxmd.com/read/28771240/selecting-a-cut-off-for-colorectal-cancer-screening-with-a-fecal-immunochemical-test
#12
Hermann Brenner, Simone Werner
OBJECTIVES: Fecal immunochemical tests (FITs) for hemoglobin (Hb) are increasingly used for colorectal cancer (CRC) screening. However, cut-offs for defining test positivity are varying widely. We aimed to evaluate the impact of cut-off selection on key indicators of diagnostic performance in a true screening setting. METHODS: We evaluated diagnostic performance of FOB Gold, a widely used quantitative FIT, for detecting advanced neoplasms (AN) across a wide range of possible cut-offs among 1822 participants of screening colonoscopy aged 50-79 years in Germany...
August 3, 2017: Clinical and Translational Gastroenterology
https://www.readbyqxmd.com/read/28764667/patterns-of-participation-over-four-rounds-of-annual-fecal-immunochemical-test-based-screening-for-colorectal-cancer-what-predicts-rescreening
#13
Joanne M Osborne, Carlene Wilson, Amy Duncan, Stephen R Cole, Ingrid Flight, Deborah Turnbull, Donna L Hughes, Graeme P Young
BACKGROUND: Participation at the recommended intervals is critical for screening to be effective in reducing colorectal cancer (CRC) incidence. This study describes patterns of screening participation over four rounds of fecal immunochemical testing (FIT) to identify whether demographic variables and prior screening satisfaction are significantly associated with patterns of re-participation. METHODS: Baseline surveys were mailed to 4000 South Australians randomly selected from the electoral-roll...
August 1, 2017: BMC Public Health
https://www.readbyqxmd.com/read/28761377/fecal-occult-blood-versus-dna-testing-indirect-comparison-in-a-colorectal-cancer-screening-population
#14
Hermann Brenner, Hongda Chen
BACKGROUND: A multitarget stool DNA test (MSDT) that showed higher sensitivity but lower specificity than a fecal immunochemical test (FIT) for hemoglobin in one recent study from the US and Canada, is increasingly used for colorectal cancer (CRC) screening, despite its ~20-fold higher costs compared to FITs. We aimed to assess diagnostic performance of a quantitative FIT in an independent study among participants of screening colonoscopy and to compare it with the previously reported performance of MSDT...
2017: Clinical Epidemiology
https://www.readbyqxmd.com/read/28760383/association-between-concentrations-of-hemoglobin-determined-by-fecal-immunochemical-tests-and-long-term-development-of-advanced-colorectal-neoplasia
#15
Esmée J Grobbee, Eline H Schreuders, Bettina E Hansen, Marco J Bruno, Iris Lansdorp-Vogelaar, Manon C W Spaander, Ernst J Kuipers
BACKGROUND & AIMS: Colorectal cancer (CRC) screening using quantitative fecal immunochemical tests (FITs) is rapidly gaining ground worldwide. FITs are invariably used in a dichotomous manner using pre-specified cut-off values. To optimize FIT-based screening programs, we investigated the association between fecal hemoglobin (fHb) concentrations below the FIT cut-off value and later development of colorectal advanced neoplasia. METHODS: We analyzed data collected from a population-based study of 9561 average-risk subjects (50-74 yrs old) in the Netherlands who were offered 4 rounds of FIT screening for CRC from November 2006 through December 2014...
July 28, 2017: Gastroenterology
https://www.readbyqxmd.com/read/28750489/patients-preferences-for-primary-colorectal-cancer-screening-a-survey-of-the-national-colorectal-cancer-screening-program-in-korea
#16
Young-Hak Cho, Dae Ho Kim, Jae Myung Cha, Yoon Tae Jeen, Jeong Seop Moon, Jin-Oh Kim, Sang Kil Lee, Yu Kyung Cho, Jong Pil Im, Jae Young Jang, Jeong Eun Shin, Soon Man Yoon, Yunho Jung, Eun Sun Kim, Kang Nyeong Lee, Soo-Jeong Cho, Yeol Kim, Bo Young Park
Background/Aims: The adoption of colonoscopy as a primary colorectal cancer (CRC) screening technique has been argued for in Korea, without evidence of patient preferences. This study aimed to investigate patients' preferences for the primary CRC screening test for the National Cancer Screening Program (NCSP). Methods: Between June and August 2016, 414 individuals aged ≥50 years who participated in the NCSP were prospectively invited to complete a questionnaire regarding their preferences for the primary CRC screening test and the reasons for their selection...
July 28, 2017: Gut and Liver
https://www.readbyqxmd.com/read/28744763/a-case-of-colonic-stenosis-caused-by-cold-snare-polypectomy-for-the-removal-of-a-colonic-polyp
#17
Naotaka Ogasawara, Masaaki Takayama, Satoshi Ono, Shunsuke Katoh, Hirohiko Komai, Yasutaka Hijikata, Masahide Ebi, Yasushi Funaki, Makoto Sasaki, Kunio Kasugai
A 78-year-old woman with hypertension had a positive fecal immunochemical test and underwent colonoscopy, which revealed a 4 mm sessile polyp (Paris type; 0-Is) in the transverse colon. Based on low magnification colonoscopy with narrow band imaging, the polyp was Type 2 according to the NBI International Colorectal Endoscopic classification, diagnosed as an adenoma, and then resected via cold snare polypectomy (CSP). Five days after CSP, she complained of right-sided abdominal pain. Abdominal CT showed focal wall thickening of the transverse colon and focal infiltration of tissues surrounding the transverse colon...
July 25, 2017: Clinical Journal of Gastroenterology
https://www.readbyqxmd.com/read/28733262/cost-effectiveness-of-high-performance-biomarker-tests-versus%C3%A2-fecal-immunochemical-test-for-noninvasive-colorectal-cancer-screening
#18
Iris Lansdorp-Vogelaar, S Lucas Goede, Linda J W Bosch, Veerle Melotte, Beatriz Carvalho, Manon van Engeland, Gerrit A Meijer, Harry J de Koning, Marjolein van Ballegooijen
BACKGROUND & AIMS: Biomarker assays could increase the accuracy of noninvasive detection of colorectal cancer (CRC); fecal immunochemical tests (FITs) are estimated to miss 27%-47% of CRCs and 70%-80% of advanced adenomas per round of screening. We investigated the conditions under which biomarker screens would be cost-effective compared with FIT screens of average-risk individuals. METHODS: We used the MISCAN-Colon microsimulation model to estimate the effects of various CRC screening test characteristics on life-years gained (LYG) and costs...
July 18, 2017: Clinical Gastroenterology and Hepatology
https://www.readbyqxmd.com/read/28730505/stool-based-testing-for-colorectal-cancer-an-overview-of-available-evidence
#19
REVIEW
Kevin M Rank, Aasma Shaukat
PURPOSE OF REVIEW: The goal of this review is to summarize stool-based testing for colorectal cancer (CRC). The key questions answered in this review were the advantages and limitations of each available stool-based test for CRC and to examine their comparative efficacy. RECENT FINDINGS: Guaiac-based fecal occult blood testing (gFOBT) is no longer a relevant test for CRC screening. fecal immunochemical testing (FIT) tests, especially quantitative assays, are clearly a reliable stool-based test...
August 2017: Current Gastroenterology Reports
https://www.readbyqxmd.com/read/28721099/sociodemographic-characteristics-of-nonparticipants-in-the-danish-colorectal-cancer-screening-program-a-nationwide-cross-sectional-study
#20
Mette Bach Larsen, Ellen M Mikkelsen, Morten Rasmussen, Lennart Friis-Hansen, Anders U Ovesen, Hans Bjarke Rahr, Berit Andersen
INTRODUCTION: Fecal occult blood tests are recommended for colorectal cancer (CRC) screening in Europe. Recently, the fecal immunochemical test (FIT) has come into use. Sociodemographic differences between participants and nonparticipants may be less pronounced when using FIT as there are no preceding dietary restrictions and only one specimen is required. The aim of this study was to examine the associations between sociodemographic characteristics and nonparticipation for both genders, with special emphasis on those who actively unsubscribe from the program...
2017: Clinical Epidemiology
keyword
keyword
80639
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"